PLANO, Tex. (Ivanhoe Newswire) -- There are one billion people in the world who have uncontrolled high blood pressure. It’s a problem that medication can’t solve for many. Now, for the first time there’s a procedure that’s zapping away this common condition.
Author, garden enthusiast, and art collector, Carl Youngberg has many titles. Including one he’d like to drop, high blood pressure patient. He’s lived with the condition since he was nine years old.
“I’ve had it forever,” Carl Youngberg told Ivanhoe.
Medications have failed to control it, so Carl enrolled in a clinical trial to test renal denervation.
“This is the first change in 100 years in the treatment of high blood pressure,” David L. Brown, MD, Co-director of Cardiovascular Research at the Heart Hospital Baylor Plano, told Ivanhoe.
The idea is to target overactive renal nerves that can cause blood pressure to soar. The nerves transmit information from the kidneys to the brain. Doctors insert a needle into an artery in the groin near the kidneys and burn the nerves.
“We take off some of that overdrive, and people feel better, and their blood pressure drops, on average, 30 points.” Cara East, MD, Cardiologist and Endocrinologist at the Baylor Heart and Vascular Hospital, told Ivanhoe.
So far it seems to be most effective for people with resistant high blood pressure, like Carl. Because he’s in a double-blind trial, Carl doesn’t know if he received the therapy, but he’s hopeful.
“I’d like to find normal to be honest with you, a new normal for me would be wonderful,” Youngberg said.
At its highest, Carl’s blood pressure was 203 over 84. The last time he checked, it was 160 over 74. Renal denervation is already approved in Canada, Australia, and Europe. Doctors believe it could be FDA approved in two to three years. Risks are extremely rare but include infections and blood clots. MORE.
Click here for Ivanhoe's full-length interview withDr. David Brown
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Andrew Mcintosh at amcintosh@ivanhoe.com
Denotes Premium Content in Latest Medical News